Double CEBPE-IGH rearrangement due to chromosome duplication and cryptic insertion in an adult with B-cell acute lymphoblastic leukemia

Cancer Genetics

Volumn 204, Issue 10, 2011, Pages 563-568

  Pierini, Valentina ^a   Nofrini, Valeria ^a   La Starza, Roberta ^a   Barba, Gianluca ^a   Vitale, Antonella ^b   Di Raimondo, Francesco ^c   Matteucci, Caterina ^a   Crescenzi, Barbara ^a   Elia, Loredana ^b   Gorello, Paolo ^a   Storlazzi, Clelia Tiziana ^d   Mecucci, Cristina ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

^d UNIVERSITY OF BARI   (Italy)

Author keywords

CEBPE IGH; CGH; FISH

Indexed keywords

CD19 ANTIGEN; CD22 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; HLA DR ANTIGEN; CCAAT ENHANCER BINDING PROTEIN; CEBPE PROTEIN, HUMAN; IMMUNOGLOBULIN HEAVY CHAIN; ONCOPROTEIN;

ADULT; ARTICLE; B CELL LEUKEMIA; BONE MARROW BIOPSY; CARCINOGENESIS; CASE REPORT; CCAAT ENHANCER BINDING PROTEIN EPSILON GENE; CHROMOSOME 14; CHROMOSOME 5; CHROMOSOME BREAKAGE; CHROMOSOME DUPLICATION; CHROMOSOME INSERTION; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 13; CHROMOSOME TRANSLOCATION 14; CLINICAL EXAMINATION; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE ASSOCIATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DOSAGE; GENE FUSION; GENE LOCATION; GENE REARRANGEMENT; GENETIC ASSOCIATION; HEPATOMEGALY; HUMAN; HUMAN TISSUE; IGH GENE; KARYOTYPE; KARYOTYPE 46,XY; LYMPHADENOPATHY; MALE; ONCOGENE; PRIORITY JOURNAL; SPLENOMEGALY; ACUTE LYMPHOBLASTIC LEUKEMIA; GENE TRANSLOCATION; GENETICS; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION;

CCAAT-ENHANCER-BINDING PROTEINS; CHROMOSOME DUPLICATION; GENE REARRANGEMENT; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; ONCOGENE PROTEINS, FUSION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TRANSLOCATION, GENETIC;

EID: 84859248848     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2011.10.005     Document Type: Article

References (28)

1. Lekstrom-Himes J.A., Xanthopoulos K.G. Biological role of the CCAAT/enhancer-binding protein of transcription factors. J Biol Chem 1998, 273:28545-28548.
2. Lekstrom-Himes J.A., Dorman S.E., Kopar P., et al. Neutrophil-specific granule deficiency results from a novel mutation with loss of function of the transcription factor CCAAT/Enhancer binding protein ε. J Exp Med 1999, 189:1847-1852.
3. Gombart A.F., Shiohara M., Kwok S.H., et al. Neutrophil-specific granule deficiency: homozygous recessive inheritance of a frameshift mutation in the gene encoding transcription factor CCAAT/enhancer binding protein-ε. Blood 2001, 97:2561-2567.
4. Gombart A.F., Koeffler H.P. Neutrophil specific granule deficiency and mutations in the gene encoding transcription factor C/EBP(epsilon). Curr Opin Hematol 2002, 9:36-42.
5. Smith M.L., Cavenagh J.D., Lister T.A., et al. Mutation of CEBPA in familial acute myeloid leukemia. N Engl J Med 2004, 2(351):2403-2407.
6. Leroy H., Roumier C., Huyghe P., et al. CEBPA point mutations in hematological malignancies. Leukemia 2005, 19:329-334.
7. Wouters B.J., Lowenberg B., Erpelinck-Verschueren C.A., et al. Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome. Blood 2009, 113:3088-3091.
8. Pabst T., Eyholzer M., Fos J., et al. Heterogeneity within AML with CEBPA mutations: only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis. Br J Cancer 2009, 100:1343-1346.
9. Green C.L., Koo K.K., Hills R.K., et al. Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations. J Clin Oncol 2010, 28:2739-2747.
10. Dufour A., Schneider F., Metzeler K.H., et al. Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome. J Clin Oncol 2010, 28:570-577.
11. Taskesen E., Bullinger L., Corbacioglu A., et al. Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity. Blood 2011, 117:2469-2475.
12. Akasaka T., Balasa T., Russell L.J., et al. Five memebrs of the CEBP transcription factor family are targeted by recurrent IGH-translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood 2007, 109:3451-3461.
13. Han Y., Xue Y., Zhang J., et al. Translocation (14;14)(q11;q32) with simultaneous involvement of the IGH and CEBPE genes in B-lineage acute lymphoblastic leukemia. Cancer Gent Cytogenet 2008, 187:125-129.
14. Mancini M., Scappaticci D., Cimino G., et al. A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol. Blood 2005, 105:3434-3441.
15. Matteucci C., La Starza R., Crescenzi B., et al. Interpretation of the complex karyotype and identification of a new 6p amplicon by integrated comparative genomic hybridization and fluorescence in situ hybridization investigations on the U937-I cell line. Cancer Genet Cytogenet 2002, 135:28-34.
16. Crescenzi B., La Starza R., Romoli S., et al. Submicroscopic deletions in 5q- associated malignancies. Haematologica 2004, 89:281-285.
17. http://www.ncbi.nlm.nih.gov.
18. Knight S.J.L., Lese C.M., Precht K.S., et al. An optimized set of human telomere clones for studying telomere integrity and architecture. Am J Hum Genet 2000, 67:320-332.
19. Zhang F., Gu W., Hurles M.E., et al. Copy number variation in human health, disease, and evolution. Annu Rev Genomics Hum Genet 2009, 10:451-481.
20. Chen J.M., Cooper D.N., Férec C., et al. Genomic rearrangements in inherited disease and cancer. Semin Cancer Biol 2010, 20:222-233.
21. Zhang F., Khajavi M., Connolly A.M., et al. The DNA replication FoSTeS/MMBIR mechanism can generate genomic, genic and exonic complex rearrangements in humans. Nat Genet 2009, 41:849-853.
22. Lee J.A., Carvalho C.M., Lupski J.R. A DNA replication mechanism for generating nonrecurrent rearrangements associated with genomic disorders. Cell 2007, 131:1235-1247.
23. Gu W., Zhang F., Lupski J.R. Mechanisms for human genomic rearrangements. Pathogenetics 2008, 1:1-17.
24. Hastings P.J., Ira G., Lupski J.R. A microhomolgy-mediated break-induced replication model for the origin of human copy number variation. PLoS Genet 2009, 5:e1000327.
25. Zahng F., Carvalho C.M.B., Lupski J.R. Complex human chromosomal and genomic rearrangements. Trends in Genet 2009, 25:298-307.
26. Preston C.R., Flores C.C., Engels W.R. Differential usage of alternative pathways of Double-Strand Break Repair in Drosophila. Genetics 2006, 172:1055-1068.
27. Saleh-Gohari N., Helleday T. Conservative homologous recombination preferentially repairs DNA double-strand breaks in the S phase of the cell cycle in human cells. Nucleic Acids Res 2004, 13:3683-3688.
28. Chapiro E., Russell L., Radford-Weiss I., et al. Overexpression of CEBPA resulting from the translocation t(14;19)(q32;q13) of human precursor B acute lymphoblastic leukemia. Blood 2006, 108:3560-3563.